In 2005, stem cell research became a priority for the Brazilian federal government. Since then, the country has established a legal framework that allows research with human embryos and regulates clinical studies with stem cells. Despite limitations in research funding, the good infrastructure and local advantages for conducting clinical research allow Brazil to significantly contribute to the advancement of regenerative medicine.

Science in Brazil

Brazil is the largest country and the largest economy in Latin America, with a population of 193.9 million and a gross domestic product (GDP) of $2,356 billion in 2012, and the largest investment in research and development—1 percent of its GDP—in the region. In 2012, Brazil contributed to 2.7 percent of the world research papers in Web of Science, a 145 percent increase ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles